CAIFX
Price
$68.64
Change
+$0.49 (+0.72%)
Updated
Dec 20 closing price
CFIHX
Price
$68.67
Change
+$0.49 (+0.72%)
Updated
Dec 20 closing price
Ad is loading...

CAIFX vs CFIHX

Header iconCAIFX vs CFIHX Comparison
Open Charts CAIFX vs CFIHXBanner chart's image
American Funds Capital Income Bldr F2
Price$68.64
Change+$0.49 (+0.72%)
VolumeN/A
CapitalizationN/A
American Funds Capital Income Bldr F3
Price$68.67
Change+$0.49 (+0.72%)
VolumeN/A
CapitalizationN/A
CAIFX vs CFIHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CAIFX vs. CFIHX commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAIFX is a Buy and CFIHX is a Buy.

FUNDAMENTALS
Fundamentals
CAIFX (105B) and CFIHX (105B) have equal amount of cash in the bank . CFIHX (3.59) and CAIFX (3.49) have matching dividends . CAIFX was incepted earlier than CFIHX: CAIFX (16 years) vs CFIHX (8 years). CAIFX (106.00) and CFIHX (106.00) have comparable annual turnover. CAIFX has a lower initial minimum investment than CFIHX: CAIFX (250) vs CFIHX (1000000). CFIHX (8.63) and CAIFX (8.52) have marching annual gain over last year. CFIHX (23.88) and CAIFX (23.44) have equivalent 5 years return.
CAIFXCFIHXCAIFX / CFIHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years8 years-
Gain YTD7.4837.59499%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets105B105B100%
Annual Yield % from dividends3.493.5997%
Returns for 1 year8.528.6399%
Returns for 3 years8.598.8297%
Returns for 5 years23.4423.8898%
Returns for 10 years33.06N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CUK24.321.49
+6.53%
Carnival PLC
MEIP2.500.05
+2.01%
MEI Pharma
KTB87.351.08
+1.25%
Kontoor Brands
MGNX3.18N/A
N/A
MacroGenics
BSIG27.01-1.01
-3.60%
BrightSphere Investment Group